Literature DB >> 11988489

Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation.

Beata M Wolska1, Grace M Arteaga, James R Peña, Grzegorz Nowak, Ronald M Phillips, Shalini Sahai, Pieter P de Tombe, Anne F Martin, Evangelia G Kranias, R John Solaro.   

Abstract

Beta-adrenergic stimulation of the heart results in an enhanced relaxation rate in association with phosphorylation of both cardiac troponin I (cTnI) and phospholamban (PLB). We studied new lines of mice generated by crossbreeding mice that express slow skeletal troponin I (ssTnI) with PLB knockout (PLBKO) mice. This crossbreeding resulted in the generation of PLB/cTnI, PLB/ssTnI, PLBKO/cTnI, and PLBKO/ssTnI mice. Perfusion with isoproterenol (ISO) significantly increased the peak amplitude of fura-2 ratio in PLB/cTnI, PLBKO/cTnI, and PLBKO/ssTnI groups of mice. However, in the presence of ISO, there were no differences in the peak amplitude of fura-2 ratio among cells isolated from hearts of PLB/cTnI, PLBKO/cTnI, and PLBKO/ssTnI mice. In cells from PLB/cTnI mice, the extent of shortening was increased and the time of relaxation was significantly decreased during beta-adrenergic stimulation. In PLBKO/cTnI cells, stimulation with ISO resulted in an increased extent of shortening and no change in time of relaxation. However, stimulation with ISO in cells isolated from PLBKO/ssTnI mice not only significantly increased the extent of cell shortening but also increased the time of relaxation. We also determined the kinetics of relaxation of papillary muscles isolated from all four groups of animals in the presence and absence of ISO. Perfusion with ISO increased the rate of relaxation only in PLB/cTnI, PLB/ssTnI, and PLBKO/cTnI muscles. During ISO stimulation, the time of relaxation was unchanged in PLBKO/ssTnI muscles. Our data directly demonstrate that phosphorylation of both PLB and cTnI contributes to increased rate of relaxation during beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988489     DOI: 10.1161/01.res.0000016962.36404.04

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae.

Authors:  Joanne Layland; Jonathan C Kentish
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

2.  Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C.

Authors:  Jonathan P Davis; Catalina Norman; Tomoyoshi Kobayashi; R John Solaro; Darl R Swartz; Svetlana B Tikunova
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

3.  Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.

Authors:  Robert D Gaffin; Shamim A K Chowdhury; Marco S L Alves; Fernando A L Dias; Cibele T D Ribeiro; Rosalvo T H Fogaca; David F Wieczorek; Beata M Wolska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-08       Impact factor: 4.733

4.  Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

Authors:  David M Ryba; Chad M Warren; Chehade N Karam; Robert T Davis; Shamim A K Chowdhury; Manuel G Alvarez; Maximilian McCann; Chong Wee Liew; David F Wieczorek; Peter Varga; R John Solaro; Beata M Wolska
Journal:  Circ Heart Fail       Date:  2019-11-05       Impact factor: 8.790

5.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

6.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

7.  A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.

Authors:  K M Broughton; J Li; E Sarmah; C M Warren; Y-H Lin; M P Henze; V Sanchez-Freire; R J Solaro; B Russell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 8.  Regulation of cardiac excitation and contraction by p21 activated kinase-1.

Authors:  Yunbo Ke; Ming Lei; R John Solaro
Journal:  Prog Biophys Mol Biol       Date:  2009-01-24       Impact factor: 3.667

9.  The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform.

Authors:  Steven J Ford; Murali Chandra
Journal:  J Physiol       Date:  2012-09-10       Impact factor: 5.182

10.  Correlations between alterations in length-dependent Ca2+ activation of cardiac myofilaments and the end-systolic pressure-volume relation.

Authors:  Grzegorz Nowak; James R Peña; Dalia Urboniene; David L Geenen; R John Solaro; Beata M Wolska
Journal:  J Muscle Res Cell Motil       Date:  2008-03-26       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.